Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > YA! , FIND IT JUST A TAD,.
View:
Post by ISAloser247 on Dec 10, 2012 10:14am

YA! , FIND IT JUST A TAD,.

SLIM....ER....Curious, that   ALL   NEWS  RELEASES,  ORIGINATE FOR THE BUNKER AT  66 street and 51 avenue.?   NEVER!  Ever,  from any of the other companies, or  institutions involved?

NEVER,  has there been a NEWS RELEASE, with -------The International Chamber of Commerce, Arbitration Council finds......., or  the FDA has concluded.......or  the European Medicines Agency has decided......  LUX has...... ILJIN , in a bid....     NO,   EVERY  NEWS  RELEASE  is filtered,  after enough time,   with  ---Dr. Foster reports,  Dr. Foster would like,  Dr. Foster , further,..............control, control the info,.  ------ control the outcome!!!!

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities